Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.
Follow-Up Questions
Lotus Bio-Technology Development Corp의 CEO는 누구입니까?
Mr. Zoltan Nagy은 2011부터 회사에 합류한 Lotus Bio-Technology Development Corp의 President입니다.
LBTD 주식의 가격 성능은 어떻습니까?
LBTD의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Lotus Bio-Technology Development Corp의 주요 사업 주제나 업종은 무엇입니까?
Lotus Bio-Technology Development Corp은 N/A 업종에 속하며, 해당 부문은 N/A입니다
Lotus Bio-Technology Development Corp의 시가총액은 얼마입니까?
Lotus Bio-Technology Development Corp의 현재 시가총액은 $0입니다